SCHEMBL1375855

SCHEMBL1375855

CCCN(CC)C(=O)CCOC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
HPGD P15428 2/20 0.48
LMNA P02545 3/20 0.46
CA12 O43570 4/20 0.40
CA9 Q16790 4/20 0.40
CA2 P00918 3/20 0.40
TSHR P16473 3/20 0.38
MAPK1 P28482 2/20 0.38
MLYCD O95822 1/20 0.37
POLB P06746 1/20 0.37
APEX1 P27695 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP3 P08254 1/20 0.35
MMP8 P22894 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1373081 0.91 ALDH1A1 (0.57) ALDH1A1HPGDLMNACA12CA9
SCHEMBL118991 0.87 LMNA (0.61) ALDH1A1HPGDLMNATSHRMAPK1
SCHEMBL1373568 0.86 ALDH1A1 (0.47) ALDH1A1HPGDLMNACA12CA9
SCHEMBL24242128 0.84 ALDH1A1 (0.50) ALDH1A1HPGDLMNACA12CA9
SCHEMBL1377026 0.84 HPGD (0.46) ALDH1A1HPGDLMNACA12CA9
SCHEMBL13317119 0.82 ALDH1A1 (0.56) ALDH1A1HPGDLMNACA12CA9
SCHEMBL1377038 0.81 HPGD (0.43) ALDH1A1HPGDLMNACA12CA9
SCHEMBL1373819 0.81 LMNA (0.45) ALDH1A1HPGDLMNACA12CA9
SCHEMBL1374559 0.81 HPGD (0.43) ALDH1A1HPGDLMNACA12CA9
SCHEMBL21738499 0.80 ALDH1A1 (0.50) ALDH1A1HPGDLMNACA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150119604-A1 METHOD FOR PRODUCING BETA-ALKOXYPROPIONAMIDE IDEMITSU KOSAN CO., LTD. (JP) 2015-04-30 US disclosed
EP-2837619-A1 METHOD FOR PRODUCING BETA -ALKOXYPROPIONAMIDE Idemitsu Kosan Co., Ltd (JP) 2015-02-18 EP disclosed
US-8563495-B2 Resist remover composition and method for removing resist using same IDEMITSU KOSAN CO., LTD. (JP) 2013-10-22 US disclosed
US-20110287995-A1 RESIST REMOVER COMPOSITION AND METHOD FOR REMOVING RESIST USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150119604-A1 METHOD FOR PRODUCING BETA-ALKOXYPROPIONAMIDE HACL2, APEH, NAAA ALDH1A1 448/4885HPGD 1082/4885LMNA 792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.